News Celebrity Entertainment Tech Gaming Health Sports Travel Miscellaneous
View story

The microbial contract biomanufacturing market is projected grow at an annualized rate of 8.7%, till 2030

Alberto Brando

12 day(s) ago in category Health

www.rootsanalysis.com

 

Roots Analysis has done a detailed study on Microbial Contract Biomanufacturing Market, 2020-2030, covering key aspects of the industry and identifying potential future growth opportunities.

 

To order this 320+ page report, which features 150+ figures and 150+ tables, please visit this link

 

Key Market Insights

 

For more information, please visit https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html

 

Table of Contents

 

  1. PREFACE

1.1.       Scope of the Report

1.2.       Research Methodology

1.3.       Chapter Outlines                     

 

  1. EXECUTIVE SUMMARY

 

  1. INTRODUCTION

3.1        Chapter Overview

3.2.       Overview of Biopharmaceuticals

 

3.3.       Expression Systems Used for Biopharmaceutical Production

3.3.1.    Microbial Expression Systems

3.3.1.1. Bacterial Expression Systems

3.3.1.2. Fungal Expression Systems

3.3.1.3. Yeast Expression Systems                   

3.3.2.    Mammalian versus Microbial Expression Systems

 

3.4.       Microbial Manufacturing Process

3.4.1.    Cell Banking

3.4.2.    Upstream Processing

3.4.3.    Fermentation

3.4.4.    Downstream Processing

 

3.5.       Overview of Contract Manufacturing

3.6.       Need for Outsourcing Microbial Biomanufacturing Operations

3.7.       Commonly Outsourced Microbial Biomanufacturing Operations

3.8.       Advantages and Risks Associated with Outsourcing Microbial Biomanufacturing                                        Operations

3.9.       Key Considerations while Selecting a CMO Partner

3.10.     Concluding Remarks     

 

 

  1. MARKET LANDSCAPE

4.1.       Chapter Overview

4.2.       Microbial Contract Biomanufacturing Market: Overall Market Landscape

4.2.1.    Analysis by Year of Establishment

4.2.2.    Analysis by Company Size

4.2.3.    Analysis by Location of Headquarters

4.2.4.    Analysis by Location of Manufacturing Facility

4.2.5.    Analysis by Scale of Operation

4.2.6.    Analysis by Type of Biologic

4.2.7.    Analysis by Type of Expression System Used

4.2.8.    Analysis by Type of Fermenter

4.2.9.    Analysis by Type of Service(s) Offered

4.2.10.  Analysis by Regulatory Accreditations / Certifications

4.3.       Regional Analysis

4.3.1.    Analysis by North America

4.3.2.    Analysis by Europe

4.3.3.    Analysis by Asia Pacific

4.3.4.    Analysis by Middle East and North Africa

 

  1. COMPANY COMPETITIVENESS ANALYSIS

5.1.       Chapter Overview

5.2.       Assumptions and Key Parameters

5.3.       Methodology

5.4.       Competitiveness Analysis

5.4.1.    Competitiveness Analysis: Companies in North America

5.4.2.    Competitiveness Analysis: Companies in Europe

5.4.3.    Competitiveness Analysis: Companies in Asia Pacific    

 

  1. COMPANY PROFILES

6.1.       Chapter Overview

6.2.       Microbial Contract Biomanufacturers based in North America

6.2.1.    AGC Biologics

6.2.1.1. Company Overview

6.2.1.2. Service Portfolio

6.2.1.3. Manufacturing Capabilities and Facilities

6.2.1.4. Recent Developments and Future Outlook

           

6.2.2.    Aldevron

6.2.2.1. Company Overview

6.2.2.2. Service Portfolio

6.2.2.3. Manufacturing Capabilities and Facilities

6.2.2.4. Recent Developments and Future Outlook

6.2.3.    BioVectra

6.2.3.1. Company Overview

6.2.3.2. Service Portfolio

6.2.3.3. Manufacturing Capabilities and Facilities

6.2.3.4. Recent Developments and Future Outlook

 

6.2.4.    Ology Bioservices

6.2.4.1. Company Overview

6.2.4.2. Service Portfolio

6.2.4.3. Manufacturing Capabilities and Facilities

6.2.4.4. Recent Developments and Future Outlook

 

6.3.       Microbial Contract Biomanufacturers Based in Europe

6.3.1.    Eurogentec

6.3.1.1. Company Overview

6.3.1.2. Service Portfolio

6.3.1.3. Manufacturing Capabilities and Facilities

6.3.1.4. Recent Developments and Future Outlook

 

6.3.2.    Northway Biotechpharma

6.3.2.1. Company Overview

6.3.2.2. Service Portfolio

6.3.2.3. Manufacturing Capabilities and Facilities

6.3.2.4. Recent Developments and Future Outlook

 

6.3.3.    Porton Biopharma

6.3.3.1. Company Overview

6.3.3.2. Service Portfolio

6.3.3.3. Manufacturing Capabilities and Facilities

6.3.3.4. Recent Developments and Future Outlook

           

6.4.       Microbial Contract Biomanufacturers Based in Asia Pacific

6.4.1.    EirGenix

6.4.1.1. Company Overview

6.4.1.2. Service Portfolio

6.4.1.3. Manufacturing Capabilities and Facilities

6.4.1.4. Recent Developments and Future Outlook

 

6.4.2.    Etinpro

6.4.2.1. Company Overview

6.4.2.2. Service Portfolio

6.4.2.3. Manufacturing Capabilities and Facilities

6.4.2.4. Recent Developments and Future Outlook

 

6.4.3.    Stelis Biopharma

6.4.3.1. Company Overview

6.4.3.2. Service Portfolio

6.4.3.3. Manufacturing Capabilities and Facilities

6.4.3.4. Recent Developments and Future Outlook

 

  1. RECENT PARTNERSHIPS

7.1.       Chapter Overview

7.2.       Partnership Models

7.3.       Microbial Contract Biomanufacturers: Recent Partnerships

7.3.1.    Analysis by Year of Partnerships

7.3.2.    Analysis by Type of Partnership Model

7.3.3.    Analysis by Scale of Operation

7.3.4.    Analysis by Type of Biologic

7.3.5.    Analysis by Focus Area

7.3.6.    Analysis by Target Therapeutic Area

 

7.3.7.    Analysis by Region

7.3.7.1. Country-Wise Distribution

7.3.7.2. Intercontinental and Intracontinental Agreements

 

7.3.8.    Most Active Players: Analysis by Number of Partnerships

 

7.4.       Microbial Contract Biomanufacturers: Mergers and Acquisitions

7.4.1.    Analysis by Year of Merger / Acquisition

7.4.2.    Analysis by Type of Acquisition 

7.4.3.    Regional Analysis 

7.4.3.1. Continent-wise Distribution 

7.4.3.2. Country-wise Distribution 

7.4.3.3. Intercontinental and Intracontinental Deals 

  

7.4.4.    Most Active Players: Analysis by Number of Acquisitions

7.4.5.    Analysis by Key Value Drivers  

7.4.5.1. Analysis by Year of Acquisition and Key Value Drivers

 

  1. RECENT EXPANSIONS

8.1.       Chapter Overview

8.2.       Microbial Contract Biomanufacturers: Recent Expansions

8.2.1.    Analysis by Year of Expansion

8.2.2.    Analysis by Type of Expansion

8.2.3.    Analysis by Scale of Operation

8.2.4.    Analysis by Type of Biologic

8.3.       Geographical Analysis

8.3.1.    Continent-wise Distribution                   

 

  1. MICROBIAL FERMENTATION TECHNOLOGY PLATFORMS

9.1.       Chapter Overview

9.2.       Technology Platforms Commonly Used for Microbial Fermentation

9.3.       Upcoming Platforms-General Technologies

 

  1. ATTRACTIVENESS COMPETITION MATRIX

10.1.     Chapter Overview

10.2.     AC Matrix: An Overview

10.2.1.  Strong Business Segment

10.2.2.  Average Business Segment

10.2.3.  Weak Business Segment

10.3.     AC Matrix: Analytical Methodology

10.4.     AC Matrix: Analyzing the Data for North America

10.5.     AC Matrix: Analyzing the Data for Europe

10.6.     AC Matrix: Analyzing the Data for Asia Pacific and Middle East

 

  1. MAKE VERSUS BUY DECISION MAKING FRAMEWORK

11.1.     Chapter Overview

11.2.     Assumptions and Parameter Definitions

11.2.1.  Scenario 1

11.2.2.  Scenario 2

11.2.3.  Scenario 3

11.2.4.  Scenario 4

11.3.     Concluding Remarks

                                                                       

  1. BIG PHARMA INITITATIVES IN MICROBIAL BIOMANUFACTURING

12.1.     Chapter Overview

12.2.     List of Microbial Biopharmaceutical Manufacturing Initiatives of Big Pharma Players

12.2.1.  Analysis by Number of Initiatives

12.2.2.  Analysis by Year of Initiative

12.2.3.  Analysis by Company and Year of Initiative

12.2.4.  Analysis by Purpose of Initiative

12.2.5.  Analysis by Company and Purpose of Initiative

12.2.6.  Analysis by Type of Initiative

12.2.7.  Analysis by Scale of Operation

12.2.8.  Analysis by Type of Drug Molecule

12.2.9.  Analysis by Type of Microbial Expression System Used              

12.2.10. Geographical Analysis by Investment Made

 

12.3.     Competitive Benchmarking of Big Pharmaceutical Players

12.3.1. Big Pharma Summary

 

  1. CASE STUDY: COMPARISON OF SMALL MOLECULE AND LARGE MOLECULE DRUGS / THERAPIES

13.1.     Chapter Overview

13.2.     Small Molecule and Large Molecule Drugs / Therapies    

13.2.1. Comparison of Key Characteristics

13.2.2. Comparison of Microbial Manufacturing Process

13.2.2.1. Microbial Contract Manufacturers Providing Services for Small Molecules

13.2.3. Comparison of Key Manufacturing-related Challenges

                                               

  1. MARKET SIZING AND OPPORTUNITY ANALYSIS

14.1.     Chapter Overview

14.2.     Key Assumptions and Forecast Methodology

14.3.     Overall Microbial Contract Biomanufacturing Market, 2020-2030

14.3.1.  Microbial Contract Biomanufacturing Market for APIs, 2020-2030

14.3.2.  Microbial Contract Biomanufacturing Market for FDFs, 2020-2030           

 

14.4.     Microbial Contract Biomanufacturing Market, 2020, 2025 and 2030: Distribution by Type of Biologic

14.5.     Microbial Contract Biomanufacturing Market, 2020, 2025 and 2030: Distribution by Type of Microbial Expression System Used

14.6.     Microbial Contract Biomanufacturing Market, 2020, 2025 and 2030: Distribution by Scale of Operation

14.7.     Microbial Contract Biomanufacturing Market, 2020, 2025 and 2030: Distribution by Type of           End User

 

14.8.      Microbial Contract Biomanufacturing Market, 2020, 2025, 2030: Distribution by Key Geographical Regions          

14.8.1.   Microbial Contract Biomanufacturing Market in North America, 2020-2030

14.8.1.1. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Proteins

14.8.1.2. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Enzymes

14.8.1.3. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Growth   Hormones

14.8.1.4. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Antibody-based Drugs

14.8.1.5. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Other Biologics

14.8.1.6. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Bacterial Cell-based Expression Systems

14.8.1.7. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Yeast Cell-based Expression Systems

14.8.1.8. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Other Microbial Cell-based Expression Systems

14.8.1.9. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Commercial Operations

14.8.1.10. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Preclinical / Clinical Operations

14.8.1.11. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Small Companies

14.8.1.12. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Mid-sized Companies

14.8.1.13. Microbial Contract Biomanufacturing Market in North America, 2020-2030: Share of Large / Very Large Companies

 

14.8.2.    Microbial Contract Biomanufacturing Market in Europe, 2020-2030

14.8.2.1. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Proteins

14.8.2.2. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Enzymes

14.8.2.3. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Growth Hormones

14.8.2.4. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Antibody-based Drugs

14.8.2.5. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Other Biologics

14.8.2.6. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Bacterial Cell-based Expression Systems

14.8.2.7. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Yeast Cell-based Expression Systems

14.8.2.8. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Other Microbial Cell-based Expression Systems

14.8.2.9. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Commercial Operations

14.8.2.10. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Preclinical / Clinical Operations

14.8.2.11. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Small Companies

14.8.2.12. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Mid-sized    Companies

14.8.2.13. Microbial Contract Biomanufacturing Market in Europe, 2020-2030: Share of Large / Very Large Companies

 

14.8.3.  Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030

14.8.3.1. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Proteins

14.8.3.2. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Enzymes

14.8.3.3. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Growth Hormones

14.8.3.4. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Antibody- based Drugs

14.8.3.5. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Other Biologics

14.8.3.6. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Bacterial Cell-based Expression Systems

14.8.3.7. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Yeast Cell-based Expression Systems

14.8.3.8. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Other Microbial Cell-based Expression Systems

14.8.3.9. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Commercial Operations

14.8.3.10. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Preclinical / Clinical Operations

14.8.3.11. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Small Companies

14.8.3.12. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Mid-sized Companies

14.8.3.13. Microbial Contract Biomanufacturing Market in Asia Pacific, 2020-2030: Share of Large / Very Large Companies

 

14.8.4.  Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030

14.8.4.1. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030: Share of Proteins

14.8.4.2. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030:            Share of Enzymes

14.8.4.3. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030:            Share of Growth Hormones

14.8.4.4. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030:            Share of Antibody-based Drugs

14.8.4.5. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030:            Share of Other Biologics

14.8.4.6. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030:            Share of Bacterial Cell-based Expression Systems

14.8.4.7. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030: Share of Yeast Cell-based Expression Systems

14.8.4.8. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030: Share of Other Microbial Cell-based Expression Systems

14.8.4.9. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030: Share of Commercial Operations

14.8.4.10. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030: Share of Preclinical / Clinical Operations

14.8.4.11. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030:          Share of Small Companies

14.8.4.12. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030:          Share of Mid-sized Companies

14.8.4.13. Microbial Contract Biomanufacturing Market in Middle East and North Africa, 2020-2030:          Share of Large / Very Large Companies

 

14.8.5.  Microbial Contract Biomanufacturing Market in Latin America, 2020-2030

 

  1. IMPACT OF COVID-19 PANDEMIC ON MICROBIAL CONTRACT BIOMANUFACTURING MARKET

15.1.     Chapter Overview

15.2.     Current Options and Recuperative Initiatives of Key Players

15.2.1.  KBI Biopharma

15.2.2.  Lonza

15.2.3.  Porton Pharma Solutions

15.2.4.  Wacker Biotech

15.2.5.  Wuxi AppTec

15.3.     Impact on Microbial Contract Biomanufacturing Market Opportunity

15.4.     Recuperative Strategies for CMO Businesses

15.4.1.  Strategies for Implementation in the Short / Mid Term

15.4.2.  Strategies for Implementation in the Long Term

 

  1. SWOT ANALYSIS

16.1.     Chapter Overview

16.2.     Strengths

16.3.     Weaknesses

16.4.     Opportunities

16.5.     Threats

16.6.     Comparison of SWOT Factors

 

  1. CONCLUDING REMARKS

17.1.     Chapter Overview

 

  1. INTERVIEW TRANSCRIPTS

18.1.     Chapter Overview

18.2.     Meteoric Biopharmaceuticals

18.2.1.  Company Snapshot

18.2.2.  Interview Transcript: Gaurav Kaushik, Managing Director and Chief Executive Officer (Q4 2019)

 

18.3.     List Biological Laboratories

18.3.1.  Company Snapshot

18.3.2.  Interview Transcript: Debbie Pinkston, Vice President, Sales and Business Development (Q3 2019)

 

18.4.     OLON

18.4.1.  Company Snapshot

18.4.2.  Interview Transcript: Andrea Conforto, Sales and Marketing-Bioservices Director)

18.5.     Luina Bio

18.5.1.  Company Snapshot

18.5.2.  Interview Transcript: Max Rossetto, General Manager-Business Development

 

18.6.     WACKER Biotech

18.6.1.  Company Snapshot

18.6.2.  Interview Transcript: Rob van Dijk, Business Development Manager (Q4 2019)

 

  1. APPENDIX 1: TABULATED DATA

 

  1. APPENDIX 2: LIST OF COMPANIES AND ORGANISTIONS

 

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Comments

More from www.rootsanalysis.com

Continuous Manufacturing Market to Grow at 15% CAGR by 2030

1 day(s) ago in category Miscellaneous by rootsanalysis

Continuous Manufacturing Market is estimated to be worth around USD 2 Billion by 2030, Growing at an annualized rate of over 15%...

0

Fragment-Based Drug Discovery Market to Reach $1.6 BN

1 day(s) ago in category Miscellaneous by rootsanalysis

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, Growing at an annualized rate of 10%...

0

HPAPI & Cytotoxic Drugs Manufacturing Market Growing at 12%

1 day(s) ago in category Miscellaneous by rootsanalysis

HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, Growing at an annualized rate of 12%...

0

Non-Viral Transfection Reagents and Systems Market: $1.4 BN

1 day(s) ago in category Miscellaneous by rootsanalysis

The non-viral transfection reagents and systems market is projected to be worth USD 1.4 billion by 2030, growing at a CAGR of 9.2%...

0

Endocannabinoid System Targeted Therapeutics Market: $5 BN

1 day(s) ago in category Miscellaneous by rootsanalysis

The endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030, growing at an annualized rate of 30%...

0

The “Neoantigen Targeted Therapies Market, 2019-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.

1 day(s) ago in category Health by Alberto Brando

  To order this detailed 320+ page report, please visit this link   Key Inclusions A detailed assessment of the current market landscape, providing information on drug developer(s), phase of development ..

0

Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration

1 day(s) ago in category Health by Alberto Brando

  The use of neoantigens in therapy has demonstrated the ability to elicit a strong T cell mediated immune response. Several therapy candidates are being investigated both as monotherapies and in combination ..

0

The neoantigen targeted therapies market is projected to grow at an annualized rate of 57%, till 2030

1 day(s) ago in category Health by Alberto Brando

  Roots Analysis has done a detailed study on Neoantigen Targeted Therapies, 2019-2030 , covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order ..

0

The neoantigen targeted therapies market is estimated to be worth USD 3 Billion in 2030, predicts Roots Analysis

1 day(s) ago in category Health by Alberto Brando

  Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to ..

1

Neoantigen targeted therapies market projected to reach USD 3 Billion by 2030, growing at an annualized rate of 57%, claims Roots Analysis

1 day(s) ago in category Health by Alberto Brando

  Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to ..

0

You could also like

locomanioteranya

1 minute(s) ago in category Miscellaneous by h5bleasted

https://content-calpoly-edu.s3.amazonaws.com/socialsciences/1/webform/8%20Ball%20Pool%20Hack%20%5B2019%20WORKING%5D%20Unlimited%20Coins%20Android%20%20iOS%20no%20human%20verification.pdf https://content-calpoly-edu.s3.amazonaws.com/socialsciences/1/webform/60%20Seconds%21%20Atomic%20Adventure%20Hack%20%5B2019%20WORKING%5D%20Unlimited%20Coins%20Android%20%20iOS.pdf ..

    1

    vmaownpoiapgwe

    9 minute(s) ago in category Miscellaneous by mineshparikh

      https://imperial.instructure.com/courses/15737/pages/watch-the-little-things-2021-online-movie-full-version

      1

      >!@Man City vs West Brom LIVE STREAM@REDDIT

      15 minute(s) ago in category Miscellaneous by tirijej238

      r/Mancityvswestbromlive: EPL Live: Manchester City vs West Brom Live Stream reddit 2020 English Premier League full match, tv channel, Reddit scores … https://www.reddit.com/r/Arsenalvsouthampton/ https://www.reddit.com/r/Mancityvswestbromlive/ ..

        0

        Best Game Hacks Online | Learn How To Hack The Popular Games From The Pros

        29 minute(s) ago in category Gaming by androidhacksite79

        Our crew worked really hard to give you the FIRST online OPERATING  AFK Arena hack . Today our team is pretty pleased to declare that we’ve finally developed the very best game cheats online that definitely ..

        1

        An Overview Of IT Sector In India

        30 minute(s) ago in category technology by rohitcool2

          While in college, I thought coming to this sector will kill my creativity and I will be living a dull and boring life with no idea of what I am doing. Today, if you read answers on quora, most people ..

        1

        123MOVIES-WATCH Wonder Woman 1984 (2020) Online Full Version Download HD

        32 minute(s) ago in category Miscellaneous by saquena@123

        https://pu-x.com/forums/topic/full-watch-locked-down-2021-full-online-free-hd/ https://pu-x.com/forums/topic/full-watch-the-little-things-2021-full-online-free-hd/ https://pu-x.com/forums/topic/full-watch-monster-hunter-2020-full-online-free-hd/ ..

          0

          Fun Game Hacks Online | The Ultimate Guide To Game Cheats

          32 minute(s) ago in category Gaming by androidcheatengines68

          Our staff worked really hard to provide you the 1ST on line FUNCTIONING  Angry Birds 2 hack . Today our team is happy to say that we’ve finally designed the most effective game cheat tools that definitely ..

          1

          Watch Inter Milan vs AC Milan live stream free Milan Derby

          36 minute(s) ago in category Miscellaneous by raselmal

          https://www.deviantart.com/ufc257fight/journal/OFFICIAL-FREE-Inter-Milan-vs-Milan-Live-Strea-868338799 https://www.deviantart.com/ufc257fight/journal/Watch-Inter-Milan-vs-Milan-Live-Stream-2021-868338800 ..

            0

            S1||E16 — Jujutsu Kaisen :: Series 1 | Episode 16

            43 minute(s) ago in category Miscellaneous by oilltpp1

            Tumblr is a place to express yourself, discover yourself, and bond over the stuff you love. It's where your interests connect you with your people. S1||E16 — Jujutsu Kaisen :: Series 1 | Episode 16 S1||E16 ..

            0

            Top Game Hacks Online | The 10 Minute Guide To Game Cheats

            44 minute(s) ago in category Gaming by androidonlinecheats76

            For a couple of days, our staff of senior game software engineers was adding increased work in refining the first functional  Pokemon Quest hack  . Today our team is extremely pleased to declare that we’ve ..

            2

            Latest numbers show lowest positivity rate for coronavirus test results in nearly a month

            The Wisconsin Department of Health Services reported the lowest positivity rate in weeks Sunday as another ..

            Spanish woman who 'died' of COVID returned 10 days later: newspaper | Reuters

            An 85-year-old woman believed by her family to have died from the coronavirus surprised her relatives ..

            COVID-19 Vaccine Appointments Available, LA County Says – NBC Los Angeles

            Residents who receive their first dose of the vaccine at a county-run large capacity vaccination site ..

            California may have highly contagious homegrown COVID-19 strain

            Scientists in California believe there is a homegrown coronavirus strain in the state that could be responsible ..

            MrBeast will literally send your message to the moon: How to enter - Dexerto

            If you've ever wanted to send a photo or video to the moon, YouTube star MrBeast is finally making your ..

            ‘Breathtaking’: Netizens react after ISS shares images of Earth from space | Trending News,The Indian Express

            Shared on the official Twitter handle of ISS, the series of pictures show the Earth's aurora viewed between ..

            New York Yankees news: Another big trade could be looming - Pinstripe Alley

            New York trying to move on from Adam Ottavino; Joc Pederson as an outfield candidate; Is Corey Kluber ..

            Reaction to the Chiefs' AFC Championship win over the Bills | NFL Primetime - YouTube

            Chris Berman and Keyshawn Johnson break down how Patrick Mahomes and the Kansas City Chiefs were able ..

            Submit your article?

            Submit your articles for more traffic to your website!

            Submit article
            © 2019 posts123.com. Imprint, All rights reserved.
            Friend sites: